Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...

A study has found that the incidence of inflammatory skin diseases is higher in affluent areas. According to the New York ...

Researchers have found in a new study published in Diabetes Research and Clinical Practice that prior psoriasis in patients with type 2 diabetes mellitus (T2DM) is associated with a ...

Arcutis Biotherapeutics surges on strong Q3 results, Zoryve growth, and a bullish FY 2026 outlook. Click here to find out why ...

Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...

Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork), a ...

For skin that can stand up to rough conditions and heal quickly — especially in winter, you need to build skin resilience, ...

While we don’t face snow, ice, and brutally cold temperatures in our Havasu oasis, winter brings a calm beauty—quiet mornings ...

Though patients with psoriasis (PsO) or psoriatic arthritis (PsA) face an elevated risk for major adverse cardiac events (MACE), the likelihood of developing these events does not significantly differ ...

Mycosis fungoides is the most common subtype, making up the vast majority of CTCL cases. While early-stage disease has an estimated five-year survival rate of 88%, it remains a difficult-to-manage ...